MedPath

Tranexamic Acid

These highlights do not include all the information needed to use TRANEXAMIC ACID INJECTION safely and effectively. See full prescribing information for TRANEXAMIC ACID INJECTION. TRANEXAMIC ACID injection, for intravenous useInitial U.S. Approval: 1986

Approved
Approval ID

6f033f1e-8c78-4c87-b870-6493944315ff

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 11, 2021

Manufacturers
FDA

Mylan Institutional LLC

DUNS: 790384502

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tranexamic acid

PRODUCT DETAILS

NDC Product Code67457-197
Application NumberANDA091657
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateNovember 16, 2016
Generic Nametranexamic acid

INGREDIENTS (2)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
TRANEXAMIC ACIDActive
Quantity: 100 mg in 1 mL
Code: 6T84R30KC1
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tranexamic Acid - FDA Drug Approval Details